Elimination of Perinatal HBV and HCV Transmission: New opportunities to improve screening, prevention and care [Hosted by NICHD]
The United States National Institutes of Health (NIH) is committed to setting research priorities that advance progress toward viral hepatitis elimination. In 2020, Dr. Harvey Alter, NIH researcher, was awarded the Nobel Prize in Medicine and Physiology for his contributions to the discovery of HCV, exemplifying the importance of NIH to hepatitis elimination efforts.
NIH and the Coalition for Global Hepatitis Elimination (CGHE) are launching a new webinar series, "Moving from Hepatitis Discovery to Elimination" to highlight ongoing research that can benefit elimination efforts, support translation of research into implementation, and identify additional research needs.
Sixth Webinar: October 14th, 3-5 pm ET
Elimination of Perinatal HBV and HCV Transmission: New opportunities to improve screening, prevent
A Virtual Symposium
Hosted by the Eunice Kennedy Shriver National Institute of Child Health and Development
Elimination of perinatal HBV and HCV transmission: Epidemiology and recommendations
Dr. Carolyn Wester, US CDC
Strategies for the elimination of mother-to-child transmission (MTCT) of hepatitis B virus
Dr. Gonzague Jourdain, Institut de Recherche pour le Développement (IRD) and Chang Mai University
Treatment of HCV in pregnancy?
Dr. Catherine Chappell, University of Pittsburgh
HBV and HCV treatment in children
Dr. Ravi Jhaveri, Northwestern University
Dr. Nahida Chakhtoura, NICHD
Dr. Craig Towers, University of Tennessee Medical Center, Knoxville
Dr. Megan McReynolds, American College of Obstetricians and Gynecologists
Dr. Poonam Mishra, US Food and Drug Administration
Dr. Neil Gupta, Coalition for Global Hepatitis Elimination